Adjuvant properties of non-phospholipid liposomes (Novasomes®) in experimental animals for human vaccine antigens

Vaccine

Volumn 14, Issue 3, 1996, Pages 219-225

  Gupta, Rajesh K ^a   Varanelli, Carole L ^b,c   Griffin, Paul ^a   Wallach, Donald F H ^b,d   Siber, George R ^a  

^a State Laboratory Institute   (United States)

^b Micro Vesicular Systems Inc   (United States)

^c Diatech Inc   (United States)

^d NONE   (United States)

Author keywords

adjuvant; diphtheria toxoid; non phospholipid liposomes; tetanus toxoid

Indexed keywords

ALUMINUM PHOSPHATE; DIPHTHERIA TOXOID; FREUND ADJUVANT; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; LIPOSOME; NOVASOME; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029872916     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00182-Z     Document Type: Article

References (31)

1. Gregoriadis, G. Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. Res. Immunol. 1992, 143, 178-185
2. Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S. and Gupta, C.K. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 1993, 11, 293-306
3. Gupta, R.K. and Siber, G.R. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 1994, 22, 53-63
4. Gupta, R.K., Rost, B.E., Relyveld, E. and Siber, G.R. Adjuvant properties of aluminum and calcium compounds. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Publishing Corporation, New York, 1995, pp. 229-248
5. Gregoriadis, G. The carrier potential of liposomes in biology and medicine (first of two parts). N. Engl. J. Med. 1976, 295, 704-710
6. Alving, C.R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Meth. 1991, 140, 1-13
7. Therien, H.-M., Shahum, E. and Fortin, A. Liposome adjuvanticity: influence of dose and protein:lipid ratio on the humoral response to encapsulated and surface-linked antigen. Cell. Immunol. 1991, 136, 402-413
8. Fries, L.F., Gordon, D.M., Richards, R.L. et al. Liposomal malaria vaccine in humans: a safe, potent adjuvant strategy. Proc. Natl Acad. Sci. USA 1992, 89, 358-362
9. Antimisiaris, S.G., Jayasekera, P. and Gregoriadis, G. Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles. J. Immunol. Meth. 1993, 166, 271-280
10. Pietrobon, P.J.F. Liposome design and vaccine development. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Publishing Corporation, New York, 1995, pp. 347-361
11. Gluck, R., Mischler, R., Brantschen, S., Just, M., Althaus, B. and Cryz, S. Jr. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. J. Clin. Invest. 1992, 90, 2491-2495
12. Fendler, J. Membrane Mimetic Chemistry. John Wiley and Sons, New York, 1982, pp. 1-522
13. Zollinger, W.D. and Boslego, J.W. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J. Immunol. Meth. 1981,46, 129-140
14. Gupta, R.K. and Siber, G.R. Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay. J. Immunol. Meth. 1995, 181, 75-81
15. Wallach, D.F.H. Method of producing high-aqueous volume multilamellar vesicles. US Pat. 4,855,090, 1989
16. Wallach, D.F.H. and Philippot, J. New type of lipid vesicle: Novasome™. In: Liposome Technology, 2nd edn (Ed. Gregoriadis, G.). CRC Press, Boca Raton, 1992, pp. 141-151
17. Gupta, R.K. and Siber, G.R. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay. Biologicals 1994, 22, 215-219
18. Maciel, R.J. Standard curve fitting in immunodiagnostics: a primer. J. Clin. Immunoassay 1985, 8, 98-106
19. Gupta, R.K., Maheshwari, S.C. and Singh, H. The titration of tetanus antitoxin IV. Studies on the sensitivity and reproducibility of the toxin neutralization test. J. Biol. Stand. 1985, 12, 143-149
20. Gupta, R.K., Higham, S., Gupta, C.K., Rost, B. and Siber, G.R. Suitability of the Vero cell method for titration of diphtheria antitoxin in the United States potency test for diphtheria toxoid. Biologicals 1994, 22, 65-72
21. van Rooijen, N. Liposomes as carrier and immunoadjuvant of vaccine antigens. In: Bacterial Vaccines (Advances in Biotechnological Processes, Volume 13) (Ed. Mizrahi, A.). Wiley-Liss, New York, 1990, pp. 255-279
22. Alving, C.R. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 1993, 187, 430-446
23. Buiting, A.M.J., van Rooijen, N. and Claassen, E. Liposomes as antigen carriers and adjuvants in vivo. Res. Immunol. 1992, 143, 541-548
24. Golding, B. Cytokine regulation of humoral immune responses. In: Topics in Vaccine Adjuvant Research (Eds Spriggs, D.R. and Koff, W.C.). CRC Press, Boca Raton, 1991, pp. 25-37
25. Martin, S., Daniel, S.L. and Rouse, B.T. Cytokine and regulation of cellular immune responses to viruses. In: Topics in Vaccine Adjuvant Research (Eds Spriggs, D.R. and Koff, W.C.). CRC Press, Boca Raton, 1991, pp. 39-50
26. Phillips, N.C. and Emili, A. Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production. Vaccine 1992, 10, 151-158
27. Shahum, E. and Therien, H.-M. Correlation between in vitro and in vivo behaviour of liposomal antigens. Vaccine 1994, 12, 1125-1131
28. Claassen, E. and Boersma, W.J.A. Characteristics and practical use of new-generation adjuvants as an acceptable alternative to Freund's complete adjuvant. Res. Immunol. 1992, 143, 475-477
29. Fortin, A. and Therien, H.-M. Mechanism of liposome adjuvanticity: an in vivo approach. Immunobiology 1993, 188, 316-322
30. van Rooijen, N. Liposomes as an in vivo tool to study and manipulate macrophage function. 41st Forum in Immunology. Res. Immunol. 1992, 143, 177-256
31. Wallach, D.F.H. and Mathur, R. Non-phospholipid liposomes: principles and bulk applications. In: Liposomes as Tools in Basic Research and Industry (Eds Philippot, J.R. and Schuber, F.). CRC Press, Boca Raton, FL, 1995, pp. 241-251